Skip to main content
. 2020 Sep 2;63(5):643–654. doi: 10.5468/ogs.20033

Fig. 2.

Fig. 2.

Survival analyses according to tumor-specific BRCA1/2 defect. Platinum-free interval (PFI), progression-free survival (PFS), and overall survival (OS) of patients with International Federation of Gynecology and Obstetrics (FIGO) stage III and IV high-grade serous tubal/ovarian cancer (HGSC). Comparison of patients with BRCA1-methylated HGSC and those with BRCA1/2-mutated HGSC to patients with BRCA1/2 wild-type non-BRCA1-methylated HGSC. In all graphs, blue curves indicate non-BRCA1-methylated; red curves indicate BRCA1-methylated; and green curves indicate BRCA1/2-mutated. HR, hazard ratio; CI, confidence interval.